Phase I Trial of Vertebral Intracavitary Cement and Samarium (VICS): Novel Technique for Treatment of Painful Vertebral Metastasis

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 3, 2009, Pages 836-842

  Ashamalla, Hani ^a   Cardoso, Erico ^a   Macedon, Mark ^a   Guirguis, Adel ^a   Weng, Lijun ^a   Ali, Shamsah ^a   Mokhtar, Bahaa ^a   Ashamalla, Michael ^a   Panigrahi, Nokul ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Bone metastases; Kyphoplasty; Palliative care; Samarium

Indexed keywords

ADVERSE EFFECT; ANTICANCER ACTIVITIES; ANTINEOPLASTIC EFFECT; BONE METASTASES; BONE METASTASIS; ETHYLENE DIAMINE; KYPHOPLASTY; MEAN AGES; NOVEL TECHNIQUES; NUCLEAR BODIES; PALLIATIVE CARE; PHASE I; PHOSPHONATES; RADIATION LEAKAGES; RADIATION SAFETY; VERTEBRAL METASTASIS; VISUAL ANALOG SCALE;

AMINES; BONE; CEMENTS; ETHYLENE; PATHOLOGY; SAMARIUM;

BONE CEMENT;

BONE CEMENT; LEXIDRONAM SAMARIUM SM 153;

ADULT; AGED; ANALGESIA; ARTICLE; BLOOD CELL COUNT; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; FEMALE; FOLLOW UP; HUMAN; KYPHOPLASTY; MALE; MORBIDITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SAFETY; SPINAL PAIN; SPINE METASTASIS; SPINE SCINTISCANNING; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; BONE CEMENTS; FEASIBILITY STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PAIN MEASUREMENT; SPINAL NEOPLASMS; VERTEBROPLASTY;

EID: 68849119561     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.060     Document Type: Article

References (34)

1. Abrams H.L., Spiro R., and Goldstein N. Metastases in carcinoma: Analysis of 1000 autopsied cases. Cancer 23 (1950) 74-85
2. Galsko C.S.B. Mechanisms of lytic and blastic metastatic disease of bone. Clin Orthop 169 (1982) 20-27
3. Perrin R.G., and Laxton A.W. Metastatic spine disease: Epidemiology, pathophysiology, and evaluation of patients. Neurosurg Clin North Am 15 (2004) 365-373
4. In: Pointllart V., Ravaud A., and Palussiere J. (Eds). Vertebral metastases (2002), Springer-Verlag, New York
5. Ryken T.C., Eichholz K.M., Gerszten P.C., et al. Evidence-based review of the surgical management of vertebral column metastatic disease. Neurosurg Focus 15 (2003) 1-11
6. Gilbert R.W., Kim J.H., and Posner J.B. Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 3 (1978) 40-51
7. Sze W.-M., Shelley M.D., Held I., et al. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy-A systematic review of randomized trials. Clin Oncol 15 (2003) 345-352
8. Wu J.S.-Y., Wong R., Johnston M., et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55 (2003) 594-605
9. Chow E., Harris K., Fan G., et al. Meta-analysis of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 19 3 Suppl (2007) S26
10. Lewington V.J. Cancer therapy using bone-seeking isotopes. Phys Med Biol 41 (1996) 2027-2042
11. McEwan A.J. Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 10 (2000) 103-114
12. Serafini A.N., Houston S.J., Resche I., et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled clinical trial. J Clin Oncol 16 (1998) 1574-1581
13. Chiras J., Depriester C., Weill A., et al. Percutaneous vertebral surgery: Techniques and indications. J Neuroradiol 24 (1997) 45-59
14. Cotten A., Dewatre F., Cortet B., et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: Effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 200 (1996) 525-530
15. Aiken R.C. Measurement of feeling using visual analog scales. Proc R Soc Med 62 (1969) 989-993
16. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
17. 153Samarium-EDTMP coupled with kyphoplasty for treatment of vertebral metastases. J Neurosurg Spine 10 (2009) 336-342
18. Patel B., and DeGroot H. Evaluation of the risk of pathologic fractures secondary to metastatic bone disease. Orthopedics 24 (2001) 612-617
19. Krishnaney A.A., Steinmetz M.P., and Benzel E.C. Biomechanics of metastatic spine cancer. Neurosurg Clin North Am 15 (2004) 375-380
20. Atalay B., Caner H., Gokce C., et al. Kyphoplasty: 2 years of experience in a neurosurgery department. Surg Neurol 64 Suppl. 2 (2005) S72-S76
21. Pflugmacher R., Schulz A., Schroeder R.J., et al. A prospective two-year follow-up of thoracic and lumbar osteolytic vertebral fractures caused by multiple myeloma treated with balloon kyphoplasty. Z Orthop Ihre Grenzgeb 145 (2007) 39-47
22. Gerszten P.C., Germanwala A., Burton S.A., et al. Combination kyphoplasty and spinal radiosurgery: A new treatment paradigm for pathological fractures. J Neurosurg Spine 3 (2005) 296-301
23. Jang J.S., and Lee S.H. Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine 2 (2005) 243-248
24. Tokunaga K., Sugiu K., Miyoshi Y., et al. Percutaneous vertebroplasty combined with radiofrequency ablation for a patient with a spinal metastatic tumor: Case report. No Shinkei Geka 33 (2005) 811-815
25. Van der Linden E., Kroft L.J., and Dijkstra P.D. Treatment of vertebral tumor with posterior wall defect using image-guided radiofrequency ablation combined with vertebroplasty: Preliminary results in 12 patients. J Vasc Interv Radiol 18 (2007) 741-747
26. Georgy B.A., and Wong W. Plasma-mediated radiofrequency ablation assisted percutaneous cement injection for treating advanced malignant vertebral compression fractures. AJNR Am J Neuroradiol 28 (2007) 700-705
27. 227Th-EDTMP: A potential therapeutic agent for bone metastasis. Nucl Med Biol 31 (2004) 901-908
28. Finlay I.G., Mason M.D., and Shelley M. Radioisotopes for the palliation of metastatic bone cancer: A systematic review. Lancet Oncol 6 (2005) 353-354
29. 153Sm ethylene diamine tetra methylene phosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 33 (1997) 1583-1591
30. Chakraborty M., Wansley E., Carrasquillo J., et al. The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing. Clin Cancer Res 14 (2008) 4241-4249
31. Anderson P., Wiseman G., Erlandson L., et al. Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clin Cancer Res 11 (2005) 6895-6900
32. Franzius C., Bielack S., Sciuk J., et al. High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma. Nuklearmedizin 38 (1999) 337-340
33. Collins C., Eary J.F., Donaldson G., et al. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: A phase I/II trial. J Nucl Med 34 (1993) 1839-1844
34. Hirsch A.E., Medich D.C., Rosenstein B.S., et al. Radioisotopes and vertebral augmentation: Dosimetric analysis of a novel approach for the treatment of malignant compression fractures. Radiother Oncol 87 (2008) 119-126